XML 58 R41.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Schedule of the Company’s Net deferred Tax Assets Significant components of the Company’s net deferred tax assets are as follows:
   As of December 31, 
   2024   2023 
   U.S. dollars
in thousands
 
Deferred tax assets        
Net operating loss carryforward  $5,688    3,315 
Other temporary differences   95    71 
Capitalized research and development costs   1,282    1,395 
Operating lease liability   17    33 
Vacation and convalescence accrual   67    50 
           
Total deferred tax assets:   7,149    4,864 
           
Deferred tax liability: Operating lease right-of-use assets   (19)   (35)
           
Total deferred tax liability   (19)   (35)
           
Net deferred tax assets:   7,130    4,829 
Less: Valuation allowance   (7,130)   (4,829)
           
Net deferred tax asset   
-
    
-
 
Schedule of the Movement of the Valuation Allowance

The movement of the valuation allowance (through income statement) is as follows:

 

   For the year ended December 31, 
   2024   2023   2022 
   U.S. dollars in thousands 
             
Balance at the beginning of the year   4,829    3,016    1,607 
Addition of valuation allowance   2,301    1,813    1,409 
                
Net change in the valuation allowance   2,301    1,813    1,409 
                
Balance at the end of the year   7,130    4,829    3,016